4.4 Review

The Sertoli cell: one hundred fifty years of beauty and plasticity

期刊

ANDROLOGY
卷 4, 期 2, 页码 189-212

出版社

WILEY
DOI: 10.1111/andr.12165

关键词

amniotes; anamniotes; blood-testis barrier; germ cell; immune privilege; immune tolerance; Sertoli cell; spermatogenesis; stem cell niche; testis

资金

  1. CNPq
  2. FAPEMIG
  3. NIH [R01 HD081244]

向作者/读者索取更多资源

It has been one and a half centuries since Enrico Sertoli published the seminal discovery of the testicular nurse cell', not only a key cell in the testis, but indeed one of the most amazing cells in the vertebrate body. In this review, we begin by examining the three phases of morphological research that have occurred in the study of Sertoli cells, because microscopic anatomy was essentially the only scientific discipline available for about the first 75years after the discovery. Biochemistry and molecular biology then changed all of biological sciences, including our understanding of the functions of Sertoli cells. Immunology and stem cell biology were not even topics of science in 1865, but they have now become major issues in our appreciation of Sertoli cell's role in spermatogenesis. We end with the universal importance and plasticity of function by comparing Sertoli cells in fish, amphibians, and mammals. In these various classes of vertebrates, Sertoli cells have quite different modes of proliferation and epithelial maintenance, cystic vs. tubular formation, yet accomplish essentially the same function but in strikingly different ways.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Endocrinology & Metabolism

Clinical Utility of Circulating Cell-Free DNA Mutations in Anaplastic Thyroid Carcinoma

Yu Qin, Jennifer R. Wang, Ying Wang, Priyanka Iyer, Gilbert J. Cote, Naifa L. Busaidy, Ramona Dadu, Mark Zafereo, Michelle D. Williams, Renata Ferrarotto, G. Brandon Gunn, Peng Wei, Keyur Patel, Marie-Claude Hofmann, Maria E. Cabanillas

Summary: This study demonstrates the value of cfDNA gene mutation analysis in aiding early diagnosis and treatment selection for ATC patients. High concordance rates were observed between the mutations detected in cfDNA and those from tumor tissue sequencing. Patients with a PIK3CA mutation in cfDNA had worse overall survival, while BRAFi therapy significantly improved survival outcomes for ATC patients.

THYROID (2021)

Article Endocrinology & Metabolism

Novel Anaplastic Thyroid Cancer PDXs and Cell Lines: Expanding Preclinical Models of Genetic Diversity

Anastasios Maniakas, Ying C. Henderson, Hu Hei, Shaohua Peng, Yunyun Chen, Yujie Jiang, Shuangxi Ji, Maria Cardenas, Yulun Chiu, Diana Bell, Michelle D. Williams, Marie-Claude Hofmann, Steve E. Scherer, David A. Wheeler, Naifa L. Busaidy, Ramona Dadu, Jennifer R. Wang, Maria E. Cabanillas, Mark Zafereo, Faye M. Johnson, Stephen Y. Lai

Summary: This study developed and characterized 6 novel ATC PDX models with 4 matching cell lines, each with distinct genetic profiles. The PDX models showed remarkable resemblance to the original patient surgical specimens and had strong concordance with the original tumor in terms of genetic characteristics. These models can serve as excellent tools for preclinical therapeutic trials.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2021)

Editorial Material Andrology

With our sincere thanks: Farewell to Manuela Simoni and welcome to Aleksander Giwercman

Marie-Claude Hofmann, Aleksander Giwercman

ANDROLOGY (2022)

Editorial Material Andrology

Andrology and humanities

Marie-Claude Hofmann, Aleksander Giwercman

ANDROLOGY (2022)

Review Endocrinology & Metabolism

Sertoli Cell-Germ Cell Interactions Within the Niche: Paracrine and Juxtacrine Molecular Communications

Marie-Claude Hofmann, Elena McBeath

Summary: This review focuses on the activation of master regulators of the niche in Sertoli cells and their targets, as well as novel molecular mechanisms underlying the regulation of growth and differentiation factors through NOTCH signaling and other pathways.

FRONTIERS IN ENDOCRINOLOGY (2022)

Review Oncology

Molecular mechanisms of resistance to kinase inhibitors and redifferentiation in thyroid cancers

Marie-Claude Hofmann, Muthusamy Kunnimalaiyaan, Jennifer R. Wang, Naifa L. Busaidy, Steven Sherman, Stephen Y. Lai, Mark Zafereo, Maria E. Cabanillas

Summary: Protein kinases play critical roles in cell survival, proliferation, and motility, and their dysregulation is common in solid tumors like thyroid cancer. Inhibiting activated protein kinases has been a breakthrough in thyroid cancer therapy, but drug resistance remains a challenge that needs to be overcome with new strategies.

ENDOCRINE-RELATED CANCER (2022)

Review Obstetrics & Gynecology

Standards in semen examination: publishing reproducible and reliable data based on high-quality methodology

Lars Bjorndahl, Christopher L. R. Barratt, David Mortimer, Ashok Agarwal, Robert J. Aitken, Juan G. Alvarez, Natalie Aneck-Hahn, Stefan Arver, Elisabetta Baldi, Lluis Bassas, Florence Boitrelle, Riana Bornman, Douglas T. Carrell, Jose A. Castilla, Gerardo Cerezo Parra, Jerome H. Check, Patricia S. Cuasnicu, Sally Perreault Darney, Christiaan de Jager, Christopher J. De Jonge, Joel R. Drevet, Erma Z. Drobnis, Stefan S. Du Plessis, Michael L. Eisenberg, Sandro C. Esteves, Evangelini A. Evgeni, Alberto Ferlin, Nicolas Garrido, Aleksander Giwercman, Ilse G. F. Goovaerts, Trine B. Haugen, Ralf Henkel, Lars Henningsohn, Marie-Claude Hofmann, James M. Hotaling, Piotr Jedrzejczak, Pierre Jouannet, Niels Jorgensen, Jackson C. Kirkman Brown, Csilla Krausz, Maciej Kurpisz, Ulrik Kvist, Dolores J. Lamb, Hagai Levine, Kate L. Loveland, Robert McLachlan, Ali Mahran, Liana Maree, Sarah Martins da Silva, Michael T. Mbizvo, Andreas Meinhardt, Roelof Menkveld, Sharon T. Mortimer, Sergey Moskovtsev, Charles H. Muller, Maria Jose Munuce, Monica Muratori, Craig Niederberger, Cristian O'Flaherty, Rafael Oliva, Willem Ombelet, Allan A. Pacey, Michael A. Palladino, Ranjith Ramasamy, Liliana Ramos, Nathalie Rives, Eduardo Rs Roldan, Susan Rothmann, Denny Sakkas, Andrea Salonia, Maria Cristina Sanchez-Pozo, Rosanna Sapiro, Stefan Schlatt, Peter N. Schlegel, Hans-Christian Schuppe, Rupin Shah, Niels E. Skakkebaek, Katja Teerds, Igor Toskin, Herman Tournaye, Paul J. Turek, Gerhard van der Horst, Monica Vazquez-Levin, Christina Wang, Alex Wetzels, Theodosia Zeginiadou, Armand Zini

Summary: Biomedical science is making rapid progress in terms of transparency, openness, and reproducibility of scientific publications, particularly in studies based on human semen examination. Two recent documents, the 6th edition of the WHO Laboratory Manual for the Examination and Processing of Human Semen, and the International Standard ISO 23162:2021, provide guidelines for authors to follow these laboratory methods and use a checklist to ensure the reliability of their studies when publishing in peer-reviewed journals.

HUMAN REPRODUCTION (2022)

Editorial Material Andrology

Editorial: Andrology Awards 2021

Aleksander Giwercman, Marie Claude Hofmann

ANDROLOGY (2022)

Article Andrology

Marking the first decade of Andrology-Conception and early development of the journal

Ewa Rajpert-De Meyts, Douglas T. Carrell, Manuela Simoni, Aleksander Giwercman, Marie-Claude Hofmann

ANDROLOGY (2022)

Review Andrology

DNA damage in testicular germ cells and spermatozoa. When and how is it induced? How should we measure it? What does it mean?

Robert John Aitken, Sheena E. M. Lewis

Summary: This review summarizes the causes and consequences of DNA damage in the male germ line, including how DNA integrity is maintained in stem cells and the increase in background mutation rates with paternal age. It explains the repair pathways activated in germ cells and spermatozoa in response to genetic damage, as well as the potential mutagenic effects of such damage on offspring. The strategies for managing high levels of DNA damage in spermatozoa to reduce risks to offspring health are also discussed.

ANDROLOGY (2023)

Article Oncology

BCL2L11 Induction Mediates Sensitivity to Src and MEK1/2 Inhibition in Thyroid Cancer

Madison M. Rose, Veronica L. Espinoza, Katelyn J. Hoff, Laura A. Pike, Vibha Sharma, Marie-Claude Hofmann, Aik Choon Tan, Nikita Pozdeyev, Rebecca E. Schweppe

Summary: Thyroid cancer is a common malignancy with limited treatment options. Inhibition of Src and MAPK pathway can enhance anti-tumor effects, and BIM may serve as a potential biomarker of response.

CANCERS (2023)

Review Biochemistry & Molecular Biology

Evidence-Based Guide to Using Artificial Introns for Tissue-Specific Knockout in Mice

Elena McBeath, Keigi Fujiwara, Marie-Claude Hofmann

Summary: Until recently, the methods for generating floxed mice have been challenging, expensive, error-prone, or time-consuming. To overcome these issues, some labs have successfully used a small artificial intron to conditionally knockout a gene of interest in mice. However, others have encountered difficulties with the technique, primarily due to incorrect splicing or insufficient knockout of the gene's protein. This article presents a guide on selecting the appropriate exon and placing the recombinase-regulated artificial intron to prevent splicing disruption and maximize mRNA degradation. Following these recommendations should increase the success rate of producing tissue-specific knockout mice using this alternative technique.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Endocrinology & Metabolism

Surgery After BRAF-Directed Therapy Is Associated with Improved Survival in BRAFV600E Mutant Anaplastic Thyroid Cancer: A Single-Center Retrospective Cohort Study

Xiao Zhao, Jennifer Rui Wang, Ramona Dadu, Naifa Lamki Busaidy, Lei Xu, Kim O. Learned, Noah N. Chasen, Thinh Vu, Anastasios Maniakas, Arturo A. Eguia, Julia Diersing, Neil D. Gross, Ryan Goepfert, Stephen Y. Lai, Marie-Claude Hofmann, Renata Ferrarotto, Charles Lu, Gary Brandon Gunn, Michael T. Spiotto, Vivek Subbiah, Michelle D. Williams, Maria E. Cabanillas, Mark E. Zafereo

Summary: This study aimed to describe the outcomes of patients with BRAF(V600E)-mutated ATC who received neoadjuvant BRAF-directed therapy followed by surgery. The results showed that neoadjuvant therapy reduced the extent of surgery and surgical morbidity, and patients treated with neoadjuvant therapy had higher overall survival and progression-free survival rates compared to those who didn't have surgery or had surgery before therapy.

THYROID (2023)

Review Endocrinology & Metabolism

Review article: new treatments for advanced differentiated thyroid cancers and potential mechanisms of drug resistance

Sarah Hamidi, Marie-Claude Hofmann, Priyanka C. C. Iyer, Maria E. E. Cabanillas, Mimi I. I. Hu, Naifa L. L. Busaidy, Ramona Dadu

Summary: The treatment of advanced, radioiodine refractory, differentiated thyroid cancers (RR-DTCs) has seen significant advancements in the past decade, leading to a paradigm shift in patient management and prognosis. Improved understanding of tumor molecular drivers and access to next generation sequencing have resulted in the development and FDA-approval of targeted therapies for RR-DTCs, including multikinase inhibitors and fusion-specific kinase inhibitors. However, current treatments are not curative, and research efforts are focused on identifying and overcoming resistance mechanisms to tyrosine kinase inhibitors.

FRONTIERS IN ENDOCRINOLOGY (2023)

Meeting Abstract Oncology

Novel in vitro targeted combination therapies for anaplastic thyroid cancer

Muthusamy Kunnimalaiyaan, Parag Parekh, Jalyn Golden, Ying Anderson, Stephen Lai, Maria Cabanillas, Marc Zafereo, Ramona Dadu, Marie-Claude Hofmann

MOLECULAR CANCER THERAPEUTICS (2021)

暂无数据